https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49984 Wed 28 Feb 2024 15:55:05 AEDT ]]> Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47085 Tue 13 Dec 2022 16:35:23 AEDT ]]> Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45364 Thu 27 Oct 2022 15:35:45 AEDT ]]> Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46923 Thu 08 Dec 2022 09:09:54 AEDT ]]>